Staging of Hepatocellular Carcinoma

Journal of Clinical and Experimental Hepatology

Volumn 4, Issue , 2014, Pages S74-S79

  Duseja, Ajay ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

BCLC; Hepatocellular carcinoma (HCC); Okuda

Indexed keywords

CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; FUNCTIONAL STATUS; HUMAN; INDIAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER FUNCTION; PRIORITY JOURNAL; REVIEW; TUMOR INVASION; TUMOR VOLUME;

EID: 84954197682     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/j.jceh.2014.03.045     Document Type: Review

References (26)

1. Bruix J., Llovet J.M. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002, 35:519-524.
2. Qin Lx, Tang Z.Y. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 2002, 8:385-392.
3. Nomura F., Ohnishi K., Tanabe Y. Clinical features, and prognosis of hepatocellular carcinoma with reference to serum alfa fetoprotein levels. Analysis of 606 patients. Cancer 1989, 64:1700-1701.
4. Marsh J.W., Dvorchik Igor, Bonham C.A., Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?. Cancer 2000, 88:538-543.
5. Sorensen J.B., Klee M., Palshof T., Hansen H.H. Performance status assessment in cancer patients. An inter observer variability study. Br J Cancer 1993, 67:773-775.
6. Chevret S., Trinchet J.C., Mathieu D., Rached A.A., Beaugrand M., Chastang C. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. J Hepatol 1999, 3:133-141.
7. Llovet J.M., Bru C., Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999, 19:329-338.
8. Llovet J.M., Bruix J. Prospective validation of the Cancer of the Liver Italian Program (CLIP) score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000, 32:679-680.
9. Okuda K., Ohtsuki T., Obata H., et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 1985, 56:918-928.
10. Chung H., Kudo M., Takahashi S., et al. Comparison of three current staging systems for hepatocellular carcinoma: Japan integrated staging score, new Barcelona Clinic Liver Cancer staging classification, and Tokyo score. J Gastroenterol Hepatol 2008, 23:445-452.
11. Chan S.L., Mo F.K., Johnson P.J., et al. Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population. J Gastroenterol Hepatol 2011, 26:340-347.
12. Shouval D. HCC: what's the score?. Gut 2002, 50:749-750.
13. Kitai S., Kudo M., Minami Y., et al. Validation of a new prognostic staging system for hepatocellular carcinoma: a comparison of the biomarker-combined Japan Integrated Staging Score, the conventional Japan Integrated Staging Score and the BALAD Score. Oncology 2008, 75(suppl 1):83-90.
14. Sirivatanauksorn Y., Tovikkai C. Comparison of staging systems of hepatocellular carcinoma. HPB Surg 2011, 2011:818217.
15. Levy I., Sherman M. Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child Pugh staging systems in a cohort of 257 patients in Toronto. Gut 2002, 50:365-369. The Liver Cancer Study Group of the University of Toronto.
16. European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012, 56:908-943.
17. Bruix J., Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011, 53:1020-1022. American Association for the Study of Liver Diseases.
18. Kim B.K., Kim S.U., Park J.Y., et al. Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma. Liver Int 2012, 32:1120-1127.
19. Katyal S., Oliver J.H., Peterson M.S., Ferris J.V., Carr B.S., Baron R.L. Extrahepatic metastases of hepatocellular carcinoma. Radiology 2000, 216:698-703.
20. Uka K., Aikata H., Takaki S., et al. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J Gastroenterol 2007, 13:414-420.
21. Ho C.L., Chen S., Yeung D.W., Cheng T.K. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma. J Nucl Med 2007, 48:902-909.
22. Chen Z.F., Liang H., Zhang X.S., et al. Value of (18) F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein. Nan Fang Yi Ke Da Xue Xue Bao 2012, 32:1615-1619.
23. Hsu C., Shen Y.C., Cheng C.C., Hu F.C., Cheng A.L. Geographic difference in survival outcome for advanced hepatocellular carcinoma: implications on future clinical trial design. Contemp Clin Trials 2010, 31:55-61.
24. Paul S.B., Chalamalasetty S.B., Vishnubhatla S., et al. Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India. Oncology 2009, 77:162-171.
25. Kumar R., Saraswat M.K., Sharma B.C., Sakhuja P., Sarin S.K. Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases. QJM 2008, 101:479-485.
26. Sarma S., Sharma B., Chawla Y.K., et al. Comparison of 7 staging systems in north Indian cohort of hepatocellular carcinoma. Trop Gastroenterol 2010, 31:271-278.